Vitamin D May Lower Inflammation In Adults With Epilepsy

Source: Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina

Summary

What was studied

This study tested whether vitamin D3 supplements could improve vitamin D levels and some blood markers linked to metabolic syndrome and atherosclerosis in adults with epilepsy.

It was a double-blind, randomized, placebo-controlled trial. Forty adults with epilepsy who were taking enzymatic antiseizure medicines were assigned to take either vitamin D3 at 2,000 IU per day or a placebo for 12 weeks. Thirty-four people finished the study, and the results were based on those who completed it.

What they found

Compared with placebo, vitamin D supplementation significantly raised blood vitamin D levels over 12 weeks. It was also associated with a greater increase in adiponectin and a greater reduction in hs-CRP.

The vitamin D group did not show significant differences from placebo for insulin resistance measured by HOMA-IR or for homocysteine. The authors suggested that vitamin D may improve some cardiovascular risk-related markers in adults with epilepsy taking enzymatic antiseizure medicines, but not all markers changed.

Limits of the evidence

This was a small study with only 40 participants enrolled and 34 completing it, so the findings are less certain. It lasted only 12 weeks, so it cannot show long-term effects. The analysis only included people who finished the study, which can sometimes affect the results.

The study measured blood markers, not actual health outcomes such as cardiovascular events or seizure control. It only included adults taking enzymatic antiseizure medicines, so the results may not apply to children, people on other antiseizure medicines, or people without epilepsy. The abstract also notes that concurrent cessation of B-vitamin supplementation may have affected homocysteine results.

For families and caregivers

For families, this study suggests that vitamin D supplements may help restore vitamin D levels in some adults with epilepsy who take certain antiseizure medicines, and may improve a few blood markers such as adiponectin and hs-CRP. That could matter because some antiseizure medicines can affect vitamin D levels.

Still, this does not show that vitamin D lowers real-world cardiovascular risk or helps seizures. Families may see this as early evidence that vitamin D status is worth discussing with a clinician, especially for people taking enzymatic antiseizure medicines.

What to watch next

Stronger evidence would come from larger, longer studies that include clinical outcomes and different age groups, and families can ask whether vitamin D testing or supplementation is appropriate for their specific antiseizure medicine.

Terms in this summary

enzymatic antiseizure medicines: Seizure medicines that affect liver enzymes and can change how the body handles certain substances, including vitamin D.
25(OH)D: The main blood test used to measure vitamin D levels.
adiponectin: A blood marker related to metabolism.
hs-CRP: A blood test that measures inflammation in the body.
HOMA-IR: A calculation from blood sugar and insulin levels that estimates insulin resistance.
homocysteine: A substance in the blood that is sometimes studied as a cardiovascular risk-related marker.
placebo: A look-alike treatment with no active medicine, used for comparison in research.